CN101361743A - 三嗪三酮砜在控制球虫病中的应用 - Google Patents

三嗪三酮砜在控制球虫病中的应用 Download PDF

Info

Publication number
CN101361743A
CN101361743A CNA2008102125294A CN200810212529A CN101361743A CN 101361743 A CN101361743 A CN 101361743A CN A2008102125294 A CNA2008102125294 A CN A2008102125294A CN 200810212529 A CN200810212529 A CN 200810212529A CN 101361743 A CN101361743 A CN 101361743A
Authority
CN
China
Prior art keywords
weight
active ingredient
ponazuril
coccidiosis
animals
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2008102125294A
Other languages
English (en)
Chinese (zh)
Inventor
G·格雷夫
I·赫普
H·-C·蒙德特
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Elanco Animal Health GmbH
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of CN101361743A publication Critical patent/CN101361743A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D251/26—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
    • C07D251/30—Only oxygen atoms
    • C07D251/34—Cyanuric or isocyanuric esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
CNA2008102125294A 2000-08-17 2001-08-06 三嗪三酮砜在控制球虫病中的应用 Pending CN101361743A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10040174A DE10040174A1 (de) 2000-08-17 2000-08-17 Verwendung von Triazintrion-Sulfonen zur Bekämpfung von Coccidiosen
DE10040174.0 2000-08-17

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CNA018175023A Division CN1469868A (zh) 2000-08-17 2001-08-06 三嗪三酮砜在控制球虫病中的应用

Publications (1)

Publication Number Publication Date
CN101361743A true CN101361743A (zh) 2009-02-11

Family

ID=7652719

Family Applications (3)

Application Number Title Priority Date Filing Date
CNA2008102125294A Pending CN101361743A (zh) 2000-08-17 2001-08-06 三嗪三酮砜在控制球虫病中的应用
CNA2006100588269A Pending CN1853635A (zh) 2000-08-17 2001-08-06 三嗪三酮砜在控制球虫病中的应用
CNA018175023A Pending CN1469868A (zh) 2000-08-17 2001-08-06 三嗪三酮砜在控制球虫病中的应用

Family Applications After (2)

Application Number Title Priority Date Filing Date
CNA2006100588269A Pending CN1853635A (zh) 2000-08-17 2001-08-06 三嗪三酮砜在控制球虫病中的应用
CNA018175023A Pending CN1469868A (zh) 2000-08-17 2001-08-06 三嗪三酮砜在控制球虫病中的应用

Country Status (23)

Country Link
US (1) US7915257B2 (cg-RX-API-DMAC7.html)
EP (1) EP1311491A1 (cg-RX-API-DMAC7.html)
JP (1) JP2004506624A (cg-RX-API-DMAC7.html)
KR (1) KR100803078B1 (cg-RX-API-DMAC7.html)
CN (3) CN101361743A (cg-RX-API-DMAC7.html)
AR (1) AR030378A1 (cg-RX-API-DMAC7.html)
AU (2) AU2001278522B2 (cg-RX-API-DMAC7.html)
BR (1) BR0113268A (cg-RX-API-DMAC7.html)
CA (1) CA2419471C (cg-RX-API-DMAC7.html)
CZ (1) CZ300020B6 (cg-RX-API-DMAC7.html)
DE (1) DE10040174A1 (cg-RX-API-DMAC7.html)
HR (1) HRP20030194A2 (cg-RX-API-DMAC7.html)
HU (1) HUP0303701A3 (cg-RX-API-DMAC7.html)
MX (1) MXPA03001429A (cg-RX-API-DMAC7.html)
MY (1) MY136518A (cg-RX-API-DMAC7.html)
NO (1) NO20030585D0 (cg-RX-API-DMAC7.html)
NZ (1) NZ524200A (cg-RX-API-DMAC7.html)
PL (1) PL359709A1 (cg-RX-API-DMAC7.html)
SK (1) SK1652003A3 (cg-RX-API-DMAC7.html)
TW (1) TW200819431A (cg-RX-API-DMAC7.html)
WO (1) WO2002014288A1 (cg-RX-API-DMAC7.html)
YU (1) YU11703A (cg-RX-API-DMAC7.html)
ZA (1) ZA200301225B (cg-RX-API-DMAC7.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111714450A (zh) * 2012-12-07 2020-09-29 法国诗华动物保健公司 用肌肉内的三嗪类组合物治疗球虫病

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004001558A1 (de) * 2004-01-10 2005-08-18 Bayer Healthcare Ag Arzneimittel zur topischen Applikation bei Tieren
DE102006038292A1 (de) * 2006-08-16 2008-02-21 Bayer Healthcare Ag Transdermale Anwendung von Triazinen zur Bekämpfung von Coccidien-Infektionen
DE102007025908A1 (de) * 2007-06-01 2008-12-04 Bayer Healthcare Ag Formulierungen enthaltend Triazinone und Eisen
SI22751A (sl) 2008-04-03 2009-10-31 Krka, D.D., Novo Mesto Toltrazuril z izboljĺ animi lastnostmi za raztapljanje
DE102009012423A1 (de) 2009-03-10 2010-09-16 Bayer Animal Health Gmbh Zubereitung auf Ölbasis
EP2740492A1 (en) 2012-12-07 2014-06-11 Ceva Sante Animale Triazine formulations with a second active ingredient and surfactant(s)
EP2740469A1 (en) * 2012-12-07 2014-06-11 Ceva Sante Animale New treatments with triazines
CN102973497A (zh) * 2012-12-13 2013-03-20 江苏恒丰强生物技术有限公司 一种托曲珠利溶液及其制备方法
US11352332B2 (en) 2018-02-26 2022-06-07 AlzeCure Pharma AB Triazine derivatives for treating diseases relating to neurotrophins
EP3578181A1 (en) 2018-06-05 2019-12-11 Bayer Animal Health GmbH Formulation for use in the simultaneous treatment of coccidial infections and iron deficiencies
GB201810668D0 (en) 2018-06-28 2018-08-15 Stiftelsen Alzecure New compounds
JP7825401B2 (ja) * 2021-09-30 2026-03-06 株式会社ジーシーR&D 主材ペースト、及び歯科用アルギン酸塩印象材

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2413722C3 (de) 1974-03-21 1982-04-08 Bayer Ag, 5090 Leverkusen Neue 1-(4-Phenoxy-phenyl)-1,3,5-triazin-Derivate, ein Verfahren zu ihrer Herstellung sowie ihre Anwendung als Arzneimittel
DE2414612A1 (de) 1974-03-26 1975-10-16 Bayer Ag 1-aryluracile, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2532363A1 (de) 1975-07-19 1977-02-03 Bayer Ag Substituierte 2-phenyl-1,2,4- triazin-3,5(2h,4h)-dione, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2718799A1 (de) 1977-04-27 1978-11-09 Bayer Ag 1-(4-phenoxy-phenyl)-1,3,5-triazin- derivate, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel und wachstumsfoerderer
US4255231A (en) * 1979-06-13 1981-03-10 Congoleum Corporation Carpet etching
DE3314739A1 (de) * 1983-04-23 1984-10-25 Bayer Ag, 5090 Leverkusen 1-(4-(4-(fluoralkylmethylthio- oder -sulfinyl- oder -sulfonyl-)phenoxy) phenyl)-1,3,5-triazin-2,4,6(1h,3h,5h)-trione, verfahren zu ihrer herstellung und ihre verwendung als coccidiosemittel
US4837029A (en) * 1987-04-06 1989-06-06 Carolina Medical Products, Inc. Low foaming, aqueously homogenizable rifampin composition
US4808404A (en) * 1988-01-11 1989-02-28 A. H. Robins Company, Inc. Live vaccine for coccidiosis utilizing coccidial sporozoites
DE19824483A1 (de) 1998-06-02 1999-12-09 Bayer Ag Halbfeste wäßrige Zubereitungen für orale Applikation von Toltrazuril-Sulfon
HK1043019B (zh) 1998-10-08 2005-05-13 高新研究公司 用於预防和治疗原虫病的组合物和方法
US6150361A (en) * 1998-12-22 2000-11-21 Bayer Corporation Triazineone compounds for treating diseases due to sarcosystis, neospora and toxoplasma
HUP0104716A3 (en) * 1998-12-22 2003-10-28 Bayer Corp Pittsburgh Triazineone compounds for treating diseases due to sarcosystis, neospora and toxoplasma and medicaments containing them

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111714450A (zh) * 2012-12-07 2020-09-29 法国诗华动物保健公司 用肌肉内的三嗪类组合物治疗球虫病

Also Published As

Publication number Publication date
US7915257B2 (en) 2011-03-29
KR100803078B1 (ko) 2008-02-18
AU2001278522B9 (en) 2002-02-25
KR20030017659A (ko) 2003-03-03
NZ524200A (en) 2005-02-25
YU11703A (sh) 2006-01-16
US20040013699A1 (en) 2004-01-22
NO20030585L (no) 2003-02-06
DE10040174A1 (de) 2002-02-28
MY136518A (en) 2008-10-31
CZ300020B6 (cs) 2009-01-14
HUP0303701A3 (en) 2006-01-30
SK1652003A3 (en) 2004-02-03
PL359709A1 (en) 2004-09-06
AU2001278522B2 (en) 2007-03-22
EP1311491A1 (de) 2003-05-21
CA2419471A1 (en) 2003-02-14
ZA200301225B (en) 2004-02-16
HRP20030194A2 (en) 2005-10-31
CN1853635A (zh) 2006-11-01
BR0113268A (pt) 2003-07-08
NO20030585D0 (no) 2003-02-06
MXPA03001429A (es) 2004-05-04
CN1469868A (zh) 2004-01-21
CA2419471C (en) 2009-10-13
AU7852201A (en) 2002-02-25
WO2002014288A1 (de) 2002-02-21
TW200819431A (en) 2008-05-01
JP2004506624A (ja) 2004-03-04
HUP0303701A2 (hu) 2004-03-29
AR030378A1 (es) 2003-08-20

Similar Documents

Publication Publication Date Title
KR20090047520A (ko) 콕시디아 감염을 구제하기 위한 트리아진의 경피 적용
HU209595B (en) Process for producing substituted 1,2,4-triazindiones and pharmaceutical preparations against parasite protozoa containing them
AU2001278522B2 (en) Use of triazinetrione sulfones for combating coccidiosis
NO320712B1 (no) Blandinger av substituerte benzimidazoler og anvendelse derav
US20030181451A1 (en) Use of triazinetrione sulfoxides for controlling coccidioses
US20070232609A1 (en) Novel Antiparasitic Combination of Active Compounds
CA2250507A1 (en) Use of substituted aryl imidazoles
CA2222517C (en) Agents for use against parasitic protozoa
HK1127299A (en) Use of triazinetrione sulphone for controlling coccidioses
MXPA97009187A (en) Agents against parasi protocols
HK1062269A (en) Use of triazinetrione sulfoxides for controlling coccidioses
HK1062303A (en) Use of triazinetrione sulfones for combating coccidiosis

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1127299

Country of ref document: HK

ASS Succession or assignment of patent right

Owner name: BAYER ANIMAL HEALTH PROMOTION CO.,LTD.

Free format text: FORMER OWNER: BAYER AG

Effective date: 20091106

C41 Transfer of patent application or patent right or utility model
TA01 Transfer of patent application right

Effective date of registration: 20091106

Address after: Germany Leverkusen

Applicant after: Bayer Animal Health GmbH

Address before: Germany Leverkusen

Applicant before: Bayer Aktiengesellschaft

C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Open date: 20090211

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1127299

Country of ref document: HK